22,516
Total Claims
$2.6M
Drug Cost
1,441
Beneficiaries
$1,794
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
+18%
Cost per patient vs peers
$1,794 vs $1,524 avg
-6%
Brand preference vs peers
12.9% vs 13.7% avg
Opioid Prescribing
0.2%
Opioid Rate
54
Opioid Claims
$364
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
87% generic
Brand: 2,890 claims · $2.1M
Generic: 19,549 claims · $461K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Rivaroxaban | 408 | $390K |
| Apixaban | 365 | $368K |
| Sacubitril/Valsartan | 359 | $366K |
| Evolocumab | 390 | $299K |
| Tirzepatide | 60 | $75K |
| Semaglutide | 59 | $71K |
| Alirocumab | 106 | $66K |
| Empagliflozin | 44 | $55K |
| Dapagliflozin Propanediol | 61 | $50K |
| Icosapent Ethyl | 117 | $50K |
| Pitavastatin Calcium | 70 | $43K |
| Icosapent Ethyl | 61 | $39K |
| Ticagrelor | 42 | $35K |
| Evolocumab | 51 | $34K |
| Labetalol Hcl | 720 | $31K |
Prescribing Profile
Patient Profile
72
Avg Age
60%
Female
1.91
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data